Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 4—April 2026

Research

Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa

Husna Ismail, Olga Perovic, Ruth Mpembe, Warren Lowman, Chetna Govind, Pieter Ekermans, Waasila Jassat, Richard Welch, and Nelesh P. GovenderComments to Author 
Author affiliation: National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa (H. Ismail, O. Perovic, R. Mpembe, W. Jassat, R. Welch, N.P. Govender); University of the Witwatersrand, Johannesburg, South Africa (R. Mpembe, W. Lowman, N.P. Govender); Vermaak and Partners/Pathcare Pathologists, Pretoria, South Africa (W. Lowman); Wits Donald Gordon Medical Centre, Johannesburg (W. Lowman); Lancet Laboratories, Durban, South Africa (C. Govind); Ampath Microbiology National Reference Laboratory, Centurion, South Africa (P. Ekermans)

Main Article

Figure 4

Numbers of Candida auris and C. parapsilosis BSIs, COVID-19 cases, and COVID-19 hospital admissions, by month, in study of accelerated increase in C. auris BSIs during COVID-19 pandemic, South Africa, January 2019–June 2022. Light red bars represent cases of C. auris BSI (private n = 3,507; public n = 421), light gray bars represent cases of C. parapsilosis BSI (private n = 4,742; public n = 1,338), orange shading represents total number of COVID-19 cases (N = 3,995,881), blue shading represents number of COVID-19 hospital admissions (private n = 231,814; public n = 254,975), dark red dotted line represents 30-day moving average for C. auris, and dark gray dotted line represents 30-day moving average for C. parapsilosis. BSI, bloodstream infection.

Figure 4. Numbers of Candida auris and C. parapsilosis BSIs, COVID-19 cases, and COVID-19 hospital admissions, by month, in study of accelerated increase in C. auris BSIs during COVID-19 pandemic, South Africa, January 2019–June 2022. Light red bars represent cases of C. auris BSI (private n = 3,507; public n = 421), light gray bars represent cases of C. parapsilosis BSI (private n = 4,742; public n = 1,338), orange shading represents total number of COVID-19 cases (N = 3,995,881), blue shading represents number of COVID-19 hospital admissions (private n = 231,814; public n = 254,975), dark red dotted line represents 30-day moving average for C. auris, and dark gray dotted line represents 30-day moving average for C. parapsilosis. BSI, bloodstream infection.

Main Article

Page created: February 07, 2026
Page updated: April 02, 2026
Page reviewed: April 02, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external